Cargando…

Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis

Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease that can lead to irreversible liver cirrhosis and cancer. Early diagnosis of NASH is vital to detect disease before it becomes life‐threatening, yet noninvasively differentiating NASH from simple steatosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Anurag, Castañeda, Tamara R., Bader, Erik, Elshorst, Bettina, Cummings, Sheila, Scherer, Petra, Bangari, Dinesh S., Loewe, Claudia, Schreuder, Herman, Pöverlein, Christoph, Helms, Mike, Jones, Seth, Zech, Gernot, Licher, Thomas, Wagner, Michael, Schudok, Manfred, de Hoop, Meltsje, Plowright, Alleyn T., Atzrodt, Jens, Kannt, Aimo, Laitinen, Iina, Derdau, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739951/
https://www.ncbi.nlm.nih.gov/pubmed/33344141
http://dx.doi.org/10.1002/advs.202002997
Descripción
Sumario:Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease that can lead to irreversible liver cirrhosis and cancer. Early diagnosis of NASH is vital to detect disease before it becomes life‐threatening, yet noninvasively differentiating NASH from simple steatosis is challenging. Herein, bifunctional probes have been developed that target the hepatocyte‐specific asialoglycoprotein receptor (ASGPR), the expression of which decreases during NASH progression. The results show that the probes allow longitudinal, noninvasive monitoring of ASGPR levels by positron emission tomography in the newly developed rat model of NASH. The probes open new possibilities for research into early diagnosis of NASH and development of drugs to slow or reverse its progression.